Cannabizetol, a Novel Cannabinoid: Chemical Synthesis, Anti-inflammatory Activity and Extraction from <i>Cannabis sativa</i> L

We report the first isolation of a previously unknown cannabinoid, cannabizetol (CBGD, <b>7</b>), from <i>Cannabis sativa</i> extracts, representing the third member of the rare class of methylene-bridged dimeric cannabinoids. The availability of a chemically synthesized standard was crucial for its unequivocal identification, thus confirming the natural occurrence of this new compound. In addition to this structural discovery, we demonstrate that cannabizetol exhibits remarkable antioxidant and skin anti-inflammatory activity, significantly higher than that observed for the known dimeric cannabinoid cannabitwinol (CBDD, <b>6</b>). These results highlight cannabizetol as a promising bioactive metabolite with potential dermatological applications. To further enable its study, we developed a continuous flow approach to optimize the preparation of these dimers, achieving a substantial reduction in reaction times.

Authors

Institutions

Publication Details

Journal
Journal of Natural Products
Published
2025-09-25
DOI
https://doi.org/10.1021/acs.jnatprod.5c00826
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabizetol, a Novel Cannabinoid: Chemical Synthesis, Anti-inflammatory Activity and Extraction from Cannabis sativa L

Valerio Fasano, Andrea Citarella, Salvatore Princiotto, Francesca Annunziata et al.
Journal of Natural Products
Cannabis and Cannabinoid Research
article

Cannabizetol, a Novel Cannabinoid: Chemical Synthesis, Anti-inflammatory Activity and Extraction from Cannabis sativa L

Valerio Fasano, Andrea Citarella, Salvatore Princiotto, Francesca Annunziata, Mario Dell’Agli, Marco Fumagalli, Andrea Pinto, Enrico Sangiovanni, Daniele Passarella, Umberto Ciriello, Giulia Benedetta Martinelli, Giuseppe Paladino, L. Pozzi, Andrea Gotti
article en

Abstract

We report the first isolation of a previously unknown cannabinoid, cannabizetol (CBGD, <b>7</b>), from <i>Cannabis sativa</i> extracts, representing the third member of the rare class of methylene-bridged dimeric cannabinoids. The availability of a chemically synthesized standard was crucial for its unequivocal identification, thus confirming the natural occurrence of this new compound. In addition to this structural discovery, we demonstrate that cannabizetol exhibits remarkable antioxidant and skin anti-inflammatory activity, significantly higher than that observed for the known dimeric cannabinoid cannabitwinol (CBDD, <b>6</b>). These results highlight cannabizetol as a promising bioactive metabolite with potential dermatological applications. To further enable its study, we developed a continuous flow approach to optimize the preparation of these dimers, achieving a substantial reduction in reaction times.

Journal of Natural ProductsVol. 88(10)
University of Opole (PL), University of Milan (IT), Linnean Society of London (GB), Repubblica e Cantone Ticino (CH), Ministerio de Defensa (ES)
Deutsches Krebsforschungszentrum, Ministero dell’Istruzione, dell’Università e della Ricerca
Openalex Percentile: Top 70%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.